Kopran Ltd.

NSE: KOPRAN  SECTOR: Pharmaceuticals & Drugs

130.4
+6.2 (4.99%)

Price Summary

Today's High

₹ 0

Today's Low

₹ 0

52 Week High

₹ 130.85

52 Week Low

₹ 16.15

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

564.01393008 Cr.

Enterprise Value

608.57873008 Cr.

No. of Shares

4.3252602 Cr.

P/E

27.14

P/B

2.32

Face Value

₹ 10

Div. Yield

0%

Book Value (TTM)

₹  56.2259

CASH

1.1508 Cr.

DEBT

45.7156 Cr.

Promoter Holding

43.78%

EPS (TTM)

₹  4.8055

Sales Growth

-8.82555903784417%

ROE

5.00755498199234 %

ROCE

7.97844151497822 %

Profit Growth

6.25515348535895 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year-8.83%
3 Year-0.42%
5 Year-11.25%

Profit Growth (in Cr.)

1 Year-13.5%
3 Year9.68%
5 Year-6.24%

ROE%

1 Year5.01%
3 Year4.48%
5 Year4.87%

ROCE %

1 Year7.98%
3 Year7.31%
5 Year8.18%

Debt/Equity

0.199

Price to Cash Flow

56.55

Interest Cover Ratio

3.63894526728953

CFO/PAT (5 Yr. Avg.)

1.3163707081207

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2019 43.78 0
Sep 2019 43.78 0
Jun 2019 43.78 0
Mar 2019 43.78 0
Dec 2018 43.78 0
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 82.9105872302661 days.

 Limitations

  • The company has shown a poor profit growth of 9.67698782245299% for the Past 3 years.
  • The company has shown a poor revenue growth of -0.415543714593658% for the Past 3 years.
  • Company has a poor ROE of 4.47930805405848% over the past 3 years.
  • Company has contingent liabilities of 85.4815 Cr.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
Net Sales 48.29 54.68 38.59 57.23 47.07
Total Expenditure 44.25 45.53 34.18 48.79 37.67
Operating Profit 4.04 9.14 4.41 8.45 9.41
Other Income 1.6 1.24 0.52 2.4 3.26
Interest 1.25 1.9 1.48 1.46 1.12
Depreciation 0.95 0.86 0.87 0.96 1.05
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.45 7.62 2.59 8.43 10.51
Tax 1.01 2.14 0.79 2.41 3.02
Profit After Tax 2.43 5.48 1.8 6.02 7.49
Adjusted EPS (Rs) 0.06 0.13 0.04 0.14 0.17

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 187.31 181.54 153.7 196.65 179.29
Total Expenditure 162.37 164.19 146.44 173.95 156.11
Operating Profit 24.94 17.35 7.26 22.7 23.18
Other Income 0.83 9.12 9.56 3.22 1.99
Interest 9.99 9.79 6.63 5.46 5.96
Depreciation 3.14 3.34 3.22 3.11 3.47
Exceptional Items -1.19 0 0 0 0
Profit Before Tax 11.44 13.35 6.96 17.36 15.73
Tax 0 4.85 2.25 4.39 4.51
Net Profit 11.44 8.5 4.71 12.97 11.22
Adjusted EPS (Rs.) 2.64 1.97 1.09 3 2.59

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 51.83 43.25 43.25 43.25 43.25
Total Reserves 144.82 157.69 162.5 175.19 186.42
Borrowings 21.98 28.06 21.89 21.71 9.67
Other N/C liabilities 2.55 -2.34 -0.95 0.65 2.64
Current liabilities 57.57 79.21 69.91 74.81 83.87
Total Liabilities 278.75 305.87 296.61 315.61 325.85
Assets
Net Block 34.98 39.34 38.15 41.88 42.95
Capital WIP 0.19 2.96 5.28 0.94 0.94
Investments 156.07 156.6 156.92 157.52 158.14
Loans & Advances 4.75 1.59 1.72 1.93 3.38
Other N/C Assets 0.01 1.49 2.63 5.92 6.21
Current Assets 82.75 103.89 91.91 107.42 114.23
Total Assets 278.75 305.87 296.61 315.61 325.85
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 11.44 13.35 6.96 17.36 15.73
Adjustment 13.21 15.81 6.04 3.32 11.64
Working Capital Changes -5.95 -24.06 2.52 -4.9 -13.53
Tax Paid -0.04 -0.91 -3.02 -3.94 -3.87
Operating Cash Flow 18.66 4.2 12.5 11.84 9.97
Investing Cash Flow -3.65 -8.88 -1.93 -4.47 0.63
Financing Cash Flow -14.99 4.64 -10.71 -7.43 -10.6
Net Cash Flow 0.02 -0.04 -0.14 -0.06 0

Corporate Actions

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.
Report us

Company News

Kopran Stock Price Analysis and Quick Research Report. Is Kopran an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kopran and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 9.9733 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kopran has a Debt to Equity ratio of 0.199 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kopran , the EPS growth was -13.5008865931694 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kopran has OPM of 12.9211362727875 % which is a bad sign for profitability.
     
  • ROE: Kopran have a poor ROE of 5.00755498199234 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Kopran

X